Thread: Chulalongkorn University Launches Human Trials of COVID-19 Vaccine

BANGKOK (NNT) - Chulalongkorn University started human trials of its COVID-19 vaccine, ChulaCov19, on Monday, with 72 volunteers receiving shots under the supervision of doctors, nurses and researchers. The tests on humans come after successful trials in monkeys and rats.


Professor Kiat Ruxrungtham said ChulaCov19 is an mRNA vaccine developed domestically, in collaboration with the University of Pennsylvania’s Professor Drew Weissman, the world-renowned scientist who invented the technology. The vaccine is made from parts of the coronavirus’s genetic material, not the whole virus.


He explained that the body uses this tiny piece of genetic material to build a spike protein, which stimulates the immune system to fight the virus in case of infection. After triggering the body to make proteins, the mRNA vaccine is destroyed and passes out of the body in a few days.


The second phase of human trials will involve 150-300 volunteers, who will receive the jab around August, to measure their immune response.


National News Bureau Of Thailand

A bit less Thai centric description of the vaccine being trialed here

Researchers Are Hatching a Low-Cost Covid-19 Vaccine - The New York Times

^ Think you are mixing up your vaccine candidates here. The Chula one being tested is NOT the vaccine in that article (which is also under trial in Thailand).

Thanks for the clarification - in any case the Mahidol / GPO vaccine in the NYT article is not the same in Misskit's article. In any case it may be of interest if it proves to be effective against the virus and can be produced at a reasonable cost throughout the developing world.

Originally Posted by mudcat

in any case the Mahidol / GPO vaccine in the NYT article is not the same in Misskit's article.

Yeah, that's what nidhogg posted, after you'd obviously confused the two.